- Article
Construction of IL-13 Receptor α2-Targeting Resveratrol Nanoparticles against Glioblastoma Cells: Therapeutic Efficacy and Molecular Effects
- Xiao-Min Lin,
- Xiao-Xiao Shi,
- Le Xiong,
- Jun-Hua Nie,
- Hai-Shan Ye,
- Jin-Zi Du and
- Jia Liu
Glioblastoma multiforme (GBM) is the most common lethal primary brain malignancy without reliable therapeutic drugs. IL-13Rα2 is frequently expressed in GBMs as a molecular marker. Resveratrol (Res) effectively inhibits GBM cell growth but has not be...